Workiva Inc. to Participate in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)-- Workiva Inc. (NYSE: WK), the world’s leading cloud platform for assured integrated reporting, today announced its planned participation at two investor conferences. Workiva's management team will present at the following events:

Raymond James, Annual Institutional Investors Conference: CFO Jill Klindt will present on March 4, 2024, at 2:15 p.m. ET.

Morgan Stanley, Technology Media and Telecom Conference: CEO Julie Iskow will present on March 4, 2024, at 3:40 p.m. ET.

The events will be webcast live and a recording will be available for a limited time under the “News and Events” section on Workiva's investor relations website

About Workiva

Workiva Inc. (NYSE: WK) is on a mission to power transparent reporting for a better world. We build and deliver the world’s leading cloud platform for assured integrated reporting to meet stakeholder demands for action, transparency, and disclosure of financial and non-financial data. Workiva offers the only unified SaaS platform that brings customers’ financial reporting, Environmental, Social, and Governance (ESG), and Governance, Risk, and Compliance (GRC) together in a controlled, secure, audit-ready platform. Our platform simplifies the most complex reporting and disclosure challenges by streamlining processes, connecting data and teams, and ensuring consistency. Learn more at workiva.com

Follow Workiva on LinkedIn

Like Workiva on Instagram

View source version on businesswire.com: https://www.businesswire.com/news/home/20240214769808/en/

Investor Inquiries:
Mike Rost
[email protected]

Media Inquiries:
Rotha Brauntz
[email protected]

Source: Workiva Inc.

You May Also Be Interested In

• Vertical Aerospace Announces Date for AGM
• NorthMin Corporation Announces Additional Barite Results Following Reanalysis of Drill Core Samples from Recently Reported High-Grade Copper and Polymetallic Intersections and Provides Update on Drill
• BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries